CELLECTAR BIOSCIENCES INC (CLRB) Stock Earnings & Estimates
NASDAQ:CLRB - US15117F8077 - Common Stock
5.29 USD
+0.23 (+4.55%)
5.21 USD
-0.08 (-1.51%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A -29.71% | N/A 67.08% | N/A 42.68% | N/A 163.95% | ||||||||||||
| EBITDA YoY % growth | -9.3M | -8.2M 11.83% | -9.09M -10.85% | -12.05M -32.56% | -11.57M 3.98% | -14.05M -21.43% | -15.16M -7.90% | -23.98M -58.18% | -28.66M -19.52% | -38.768M -35.27% | -51.486M -32.80% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -9.67M | -8.56M 11.48% | -9.45M -10.40% | -13.6M -43.92% | -11.65M 14.34% | -14.18M -21.72% | -15.3M -7.90% | -24.13M -57.71% | -28.81M -19.39% | -38.961M -35.23% | -51.778M -32.90% | N/A 51.53% | N/A -1.55% | N/A 2.20% | N/A 55.74% | N/A 47.85% | N/A 245.57% | N/A 176.56% | N/A 170.24% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -107.00 -94.26% | -60.60 43.36% | -19.70 67.49% | -9.00 54.31% | -4.30 52.22% | -4.05 5.81% | -2.93 27.65% | -2.97 -1.37% | N/A -487.16% | N/A 10.88% | N/A 24.66% | N/A 86.44% | N/A 185.76% | N/A 177.90% | N/A 66.85% | N/A -55.74% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -2.81 -602.95% | -2.82 -56.59% | -5.00 -19.00% | -5.08 -49.84% | -5.71 -102.96% | -5.79 -105.37% |
| Revenue Q2Q % growth | ||||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -6.083M 54.36% | -6.333M 50.31% | -6.444M -0.68% | -6.58M -8.99% | -7.107M -16.83% | -7.244M -14.37% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -3.39 -11,200.00% | -3.98 | 0.59 | 14.78% |
| Q1 2025 Q2Q % growth | -4.20 -467.57% | -5.00 | 0.80 | 15.96% |
| Q4 2024 Q2Q % growth | -1.80 -195.08% | -10.79 | 8.99 | 83.31% |
| Q3 2024 Q2Q % growth | -0.40 51.81% | -0.38 | -0.02 | -5.28% |
| Q2 2024 Q2Q % growth | -0.03 95.89% | -0.35 | 0.32 | 91.47% |
| Q1 2024 Q2Q % growth | -0.74 2.63% | -0.57 | -0.17 | -28.79% |
| Q4 2023 Q2Q % growth | -0.61 -10.91% | -0.58 | -0.03 | -4.92% |
| Q3 2023 Q2Q % growth | -0.83 35.16% | -0.54 | -0.29 | -55.00% |
| Q2 2023 Q2Q % growth | -0.73 40.16% | -0.65 | -0.08 | -12.41% |
| Q1 2023 Q2Q % growth | -0.76 24.00% | -0.88 | 0.12 | 14.11% |
| Q4 2022 Q2Q % growth | -0.55 38.89% | -1.10 | 0.55 | 49.84% |
| Q3 2022 Q2Q % growth | -1.28 -28.00% | -1.24 | -0.04 | -3.43% |
| Q2 2022 Q2Q % growth | -1.22 -10.91% | -1.06 | -0.16 | -15.56% |
| Q1 2022 Q2Q % growth | -1.00 23.08% | -1.02 | 0.02 | 1.96% |
| Q4 2021 Q2Q % growth | -0.90 -28.57% | -1.05 | 0.15 | 13.92% |
| Q3 2021 Q2Q % growth | -1.00 33.33% | -1.12 | 0.12 | 10.87% |
| Q2 2021 Q2Q % growth | -1.10 57.69% | -1.17 | 0.07 | 5.95% |
| Q1 2021 Q2Q % growth | -1.30 69.05% | -1.04 | -0.26 | -24.46% |
| Q4 2020 Q2Q % growth | -0.70 78.79% | -1.49 | 0.79 | 52.99% |
| Q3 2020 Q2Q % growth | -1.50 64.29% | -2.04 | 0.54 | 26.47% |
| Q2 2020 Q2Q % growth | -2.60 43.48% | -3.02 | 0.42 | 13.88% |
| Q1 2020 Q2Q % growth | -4.20 44.74% | -3.54 | -0.66 | -18.78% |
| Q4 2019 Q2Q % growth | -3.30 | -3.77 | 0.47 | 12.56% |
| Q3 2019 Q2Q % growth | -4.20 | -3.88 | -0.32 | -8.36% |
| Q2 2019 Q2Q % growth | -4.60 | -7.09 | 2.49 | 35.11% |
| Q1 2019 Q2Q % growth | -7.60 | -7.55 | -0.05 | -0.69% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 30.65% | -1244.72% | -4.09% | -2749.45% |
| Revenue | N/A | N/A | N/A | N/A |